IBW & Adjusted Body Weight Calculator
Height Units
centimetres
for formula accuracy
kg — for AdjBW & dosing
Showing formula
Ideal Body Weight
kg (Devine)
Adjusted Body Weight
kg (if obese)
All Formula Results
Devine (1974)
Robinson (1983)
Miller (1983)
Hamwi (1964)
💊 Drug Dosing Quick Reference
Tidal Volume (6 mL/kg IBW)
Gentamicin 5 mg/kg AdjBW
Enoxaparin 1 mg/kg ABW
Use weight for dosing

IBW Formulas — Complete Reference

Four validated formulas exist for calculating ideal body weight. They were all derived from different populations and different time periods, which explains why their results differ by up to 10%. The choice of formula depends on the clinical context.

Devine (1974) — Most widely used clinically
Male: IBW = 50 + 2.3 × (height in inches − 60)
Female: IBW = 45.5 + 2.3 × (height in inches − 60)

Robinson (1983)
Male: IBW = 52 + 1.9 × (height in inches − 60)
Female: IBW = 49 + 1.7 × (height in inches − 60)

Miller (1983)
Male: IBW = 56.2 + 1.41 × (height in inches − 60)
Female: IBW = 53.1 + 1.36 × (height in inches − 60)

Hamwi (1964) — Used by nutritionists
Male: IBW = 48 + 2.7 × (height in inches − 60)
Female: IBW = 45.5 + 2.2 × (height in inches − 60)

Adjusted Body Weight (AdjBW) Formula

When actual body weight exceeds IBW by more than 20–30%, use AdjBW instead of IBW for drug dosing:

AdjBW = IBW + 0.4 × (Actual Body Weight − IBW)

The 0.4 correction factor (40%) accounts for the partial drug distribution into excess adipose tissue. Adipose tissue is not completely inert — it has a blood supply and some drug uptake, but significantly less than lean tissue.

FormulaYearBasisBest Used For
DevineMost Common1974Originally for digoxin dosing, based on actuarial tablesDrug dosing, ventilator tidal volume (ARDSNet)
Robinson1983Revised Devine with population dataGeneral drug dosing, tends to be lower than Devine
Miller1983Alternative regression from same dataset as RobinsonGives intermediate values, rarely used alone
Hamwi1964Dietetic practice, Metropolitan Life tablesNutritional assessment, dietetics, not drug dosing

Clinical Uses of Ideal Body Weight

1. Mechanical Ventilation — The Most Critical Use

The ARDSNet protocol (NEJM 2000, n=861) demonstrated that lung-protective ventilation using 6 mL/kg IBW (versus 12 mL/kg) reduced ARDS mortality from 39.8% to 31%. This landmark trial established IBW-based tidal volume as the standard of care in ARDS. The key insight: lung size correlates with height, not body weight. An obese patient at 150 kg has the same lung capacity as a lean person of the same height — overdistension in obesity causes volutrauma.

In practice: Set initial Vt = 6 mL/kg IBW. If plateau pressure >30 cmH₂O, reduce to 4–5 mL/kg IBW. Never increase beyond 8 mL/kg IBW regardless of CO₂.

2. Aminoglycoside Dosing (Gentamicin, Amikacin, Tobramycin)

Aminoglycosides are hydrophilic — they distribute primarily into lean tissue and extracellular fluid, with minimal penetration into adipose tissue. In obese patients, using actual body weight significantly overestimates the volume of distribution and leads to toxicity (nephrotoxicity, ototoxicity). The correct weight for aminoglycoside dosing is:

Extended interval (once-daily) dosing: 5–7 mg/kg AdjBW for gentamicin. Always follow with therapeutic drug monitoring (TDM) — trough levels at 18 hours for extended interval dosing.

3. LMWH (Enoxaparin) in Obesity

Low molecular weight heparins are dosed on actual body weight (ABW) in most patients. However, in extreme obesity (ABW >150 kg or BMI >50), evidence is limited. Many guidelines recommend anti-Xa monitoring in patients >100 kg on therapeutic enoxaparin. For prophylactic doses, standard dosing applies up to most weight ranges with some protocols using enoxaparin 40 mg BD in BMI >40.

4. Vancomycin

Unlike aminoglycosides, vancomycin uses actual body weight for initial dosing in all patients including the obese, because vancomycin has a larger volume of distribution that includes adipose tissue. AUC-guided monitoring (target AUC/MIC 400–600) is now preferred over trough-only monitoring per ASHP/IDSA/SIDP 2020 guidelines.

5. Phenytoin

Phenytoin loading dose uses AdjBW in obesity: Loading dose = 20 mg/kg AdjBW (max 2000 mg). Maintenance uses IBW-based calculations due to its saturable (Michaelis-Menten) kinetics. Always monitor free phenytoin levels in hypoalbuminaemia and renal failure.

6. Nutritional Assessment

IBW is used to calculate percentage of ideal body weight (%IBW = Actual weight ÷ IBW × 100) for nutritional status assessment. %IBW <70% indicates severe malnutrition. Caloric requirements are often based on IBW (25–30 kcal/kg IBW/day) rather than actual weight in obese patients to avoid overfeeding.

Limitations of IBW Formulas

IBW formulas were derived from predominantly Caucasian populations and may not be accurate for other ethnic groups. Studies show that Asian populations, including South Asians, have higher body fat percentage at the same BMI and height compared to Caucasians. The formulas also do not account for age-related muscle loss (sarcopenia), body composition differences between athletes and sedentary individuals, or conditions affecting body composition (oedema, ascites, amputations).

For amputees, IBW must be corrected for the missing limb weight: upper arm 3.5%, forearm 2.3%, hand 0.8%, thigh 11.6%, lower leg 5.3%, foot 1.8% of total body weight.

Frequently Asked Questions

Related Clinical Calculators

⚠ Medical Disclaimer: IBW and AdjBW are pharmacokinetic tools for drug dosing calculations. They do not define a healthy weight or body composition goal. Drug dosing must be confirmed against current prescribing guidelines, local protocols, and therapeutic drug monitoring where applicable. Always consult a clinical pharmacist for complex dosing decisions in critically ill or obese patients.